BRD2 Knockout HAP1 Cell Line

The choice depends on whether you are studying BRD2's role as a BET (bromodomain and extra-terminal) family chromatin reader or modeling BET inhibitor pharmacology. The Knockout line is the standard tool for asking whether BRD2 is required for these processes — BRD2 is a member of the BET family (BRD2, BRD3, BRD4, BRDT) that recognizes acetyl-lysine marks on histone tails and transcription factors through tandem bromodomains; BET proteins recruit P-TEFb to active enhancers and drive transcriptional elongation, with critical roles in MYC and other oncogene expression. Overexpression is useful for studying BRD2 in heterologous expression contexts. Important consideration: BET family (BRD2, BRD3, BRD4) members share substantial substrate scope — single BRD2 knockout may show modest phenotypes if BRD3/BRD4 compensate. Rescue with wild-type or bromodomain-mutant BRD2 (N156A/N429A in BD1/BD2 asparagine of acetyl-lysine binding pocket) is the standard specificity control. The knockout is a critical specificity tool for pan-BET inhibitors (JQ1, OTX015/birabresib, molibresib/iBET-762, mivebresib, pelabresib) and BD1- or BD2-selective BET inhibitors (RVX-208/apabetalone for BD2-selective) in cancer drug development; also relevant for emerging BET-targeted PROTACs (ARV-771, dBET1).

Primary applications: • BET inhibitor specificity: critical genetic control for pan-BET inhibitors (JQ1, OTX015/birabresib, molibresib/iBET-762, mivebresib, pelabresib) and BD-selective inhibitors (RVX-208/apabetalone BD2-selective). • BET-targeted PROTAC specificity: ARV-771, dBET1, MZ1 PROTAC pharmacology. • BET family dissection: BRD3, BRD4 expression analysis to interpret BRD2-specific functions. • MYC oncogene regulation: BET-MYC axis analysis given BRD family role in MYC enhancer biology. EDITGENE recommends this model for researchers investigating BET family biology and BET-targeted cancer drug development.

Yes. BRD2 rescue experiments are well-established for BET inhibitor research: • Construct design: use a codon-modified BRD2 sequence with a small C-terminal tag (FLAG, HA). BRD2 has two bromodomains (BD1, BD2) and extra-terminal (ET) domain — preserve all elements. • Bromodomain-mutant rescue: N156A (BD1) and N429A (BD2) asparagine mutations in the acetyl-lysine binding pocket abolish acetyl-mark recognition — useful for BD-selective inhibitor research. • ET-domain-mutant rescue: ET domain mutations disrupt P-TEFb recruitment. • Functional readout: rescue should restore acetyl-histone-dependent chromatin recruitment. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.